LEXX: lexariabioscience.com Stock Price

Lexaria Bioscience (LEXX) operates by licensing a unique substance transport method across tissues, the success of which depends on tests for hypertension and diabetes treatments. This price chart illustrates the asset's dynamics, with a current valuation of 4.66. Capitalization growth is supported by DehydraTECH patents and advancements in GLP-1 development, while raw material logistics optimization minimizes costs to maintain high operating profit.

Lexaria Bioscience Corp. - LEXX Share Price (period 07/04/2022 - 11/11/2026)

Lexaria - analytical breakdowns and key metrics (LEXX)

- stock value and consensus price forecast:

Price Chart Lexaria Bioscience|LEXX - Price Target Chart

- market capitalization information:

Market Capitalization Lexaria Bioscience Corp|LEXX - Total Enterprise Value

- book capitalization information:

Accounting Value per Share Lexaria Bioscience|LEXX - Accounting Capitalization|Market Cap to Net Assets Ratio lexariabioscience.com|LEXX - Total Business Assets

- debt level and financial liquidity data:

- financial results and valuation multiples details:

LEXX - Net Income|Projected Future Earnings Lexaria Bioscience|LEXX - P/E Multiple|Projected Price to Earnings Lexaria Bioscience|LEXX - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Lexaria Bioscience Corp|LEXX - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Lexaria Bioscience|LEXX - Earnings per share for the last four quarters|Quarterly EPS earnings growth lexariabioscience.com|LEXX - Earnings per share increase in current year|Earnings growth forecast for next year Lexaria Bioscience

Fundamental valuation:Lexaria Bioscience Corp.

Licensing of the innovative DehydraTECH platform provides Lexaria Bioscience (LEXX) with a high-margin royalty stream, establishing a foundation for stable free cash flow. A real-time assessment of quotes allows for an evaluation of the market consensus regarding the value of this asset, where price action serves as an integral indicator of the balance between supply and demand, confirming the long-term investment attractiveness and resilience of the business.

Analysis of competing companies